Target intelligence / Profile preview

RNA, U6 small nuclear 1136, pseudogene (RNU6-1136P)

Target
RNU6-1136P
Molecular classification
Other (pseudogene), Non-coding RNA pseudogene
01

Overview

RNA, U6 small nuclear 1136, pseudogene (RNU6-1136P) is classified as a pseudogene derived from the U6 small nuclear RNA (snRNA) gene family, specifically annotated as pseudogene number 1136 in humans[4][5]. U6 snRNA itself is an evolutionarily conserved, non-coding RNA essential for pre-mRNA splicing as part of the spliceosome complex[1][3]. However, pseudogenes like RNU6-1136P are non-functional genomic copies or partial copies of the parent U6 snRNA gene. They generally do not encode functional RNA products due to sequence alterations or lack of necessary regulatory elements[5]. Although some pseudogenes can perform regulatory roles (e.g., as competing endogenous RNAs), there is no report demonstrating RNU6-1136P has such a function[2][6]. This pseudogene is not considered a therapeutic target, nor is it involved in drug interactions, named as a biomarker, or associated with direct safety concerns. It serves mostly as an annotated genomic sequence with sequence similarity to U6 snRNA family genes[4][5].

Other names
RNU6-1136PRNA, U6 small nuclear 1136, pseudogene
02

Biological functions

Other (no established function; pseudogene of U6 snRNA)
03

Disease associations

Other (no known direct disease involvement; general pseudogenes may be aberrantly expressed in cancer, but no direct role established for RNU6-1136P)

Beyond the preview

Go deeper on RNA, U6 small nuclear 1136, pseudogene (RNU6-1136P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 1136, pseudogene (RNU6-1136P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call